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Summary
Most bacteria possess a cel l  wal l  cornposed of peptidoglycan. which protects them from
hazardous inf luences from the environrnent in which they l ive. Peptidoglycan is Él
heteropolymer bui l t  Lrp of l inear glycan chains of alternating B- 1,4-l inked N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) residues, cross-l inked by
short peptides attached to the D-lactyl groups of the MurNAc residues. In E. cr.,/i these
pepticles contain l-alanine-D-glutamyl-nr-diarninopimelyl-D-alanine, of which 40-507o are
cross-l inked by peptide bridges. The peptidoglycan forms a bag-shaped structure. the murein
sacculus, which completely encloses the bacterial cel l .  The murein sacculus maintains the
shape and size of the cel l ,  provides mechanical support,  and prevents the bacterium from
osrnotic lysis. The importance of peptidoglycan is highl ighted by the fact that several
eff lcacious antibiot ics inhibit  i ts biosynthesis. By inhibit ing the enzymes involved in cel l  wal l
biosynthesis, the cel l  wal l  gets severely damaged, and the cel l  lyses because of the high
internal osmotic pressure. Penici l l in and related B-lactams al 'e examples of such very eÍ1'ect ive
and widely appl ied antibacterials that interfere with the murein biosynthesis, causing cel l  lysis
and death. However, the rapid spread of resistance against B-lactam and other antibiot ics is
causing a serious health problem, creating an urgent need Íor alternative antibiot ics and new
antibiot ic targets. Such potential new targets could be the B-lactam insensit ive lyt ic
transglycosylases (LTs), which act on the glycosidic bonds in peptidoglycan. and which
part icipate in peptidoglycan maintenance and processing as, for example. required during cel l
septat ion and division. Specif ical ly. these enzymes catalyse the cleavage of the 0-( 1.4)-
glycosidic bond between MurNAc and GlcNAc residues in peptidoglycan. Although similar
in act ion to lysozymes. the lyt ic transglycosylases generate dif ferent reaction products. While
lysozymes cleave the B-1.4-glycosidic bond via a hydrolyt ic reaction producing muramyl
residues with a reducing end, LTs perform an intramolecular 
-elycosyltransferase reaction
between the C I ancl 06 atoms of the MurNac residue, result ing in the Íbrmation of non-
reducing 1.6 anhydromuramyl residues. The molecular basis of this dif ference in product
specif ici ty is however not known. More specif ic questions are how in the lyt ic
transglycosylases water is excluded from the active site, how the oxo-carbenium ion is
stabi l ized, and how the - I  carbohydrate residue is brought into a conformation that faci l i tates
attack of its C I atom by the 06 atom. Furthermore, the transglycosylase reaction is unique to
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bacteria and to some bacteriophages and inhibit ion of lyt ic transelycosylases appears to
enhance the efÍ ' icacy of B-lactam antibiot ics. Therefbre, the lyt ic transglycosylases seem
interesting targets Íor novel structure-based rug design.
This thesis describes the determination and analysis of the 3D-structure of the lyt ic
transglycosylase MltA from Esc'f terichia col i  by X-ray crystal lography. This work aims to
l 'urther increase our knowledge of the molecular detai ls of the cleaving mechanism and the
typical 1.6-anhydromuropeptide production by the lyt ic transglycosylases Í}om Ësc'f tericl t ict
c'ol i .
Chapter I  gives a general overview of the present knowledge of the bacterial cel l  wal l
structure. antibiot ic resistance and the lyt ic transglycosylases. Furthermore, the X-ray
structures of known lyt ic transglycosylases are summarized together which their proposed
catalyt ic rnechanisrn. ln addit ion, the reaction mechanisrns are discussed of ot lrer structural ly
or f i rnct ional ly related enzynres that cleave B- 1,4-glycosidic bonds.
Chapter 2 describes the prel iminary work involved in the structure deternrination of
MltA. A soluble lorm of the lyt ic transglycosylase MltA (sMltA) with i ts r.nembrane anchor
and si-qnal sequence deleted was over-expressed in Esclrcric'hia utli and purified to
homogeneity by rreans of cation-exchange chromatography. Rod-shaped protein crystals
were obtained, using the hanging drop method, which dif Íractecl Ío 2.2 À resolut ion. The
crysta ls  be lon-e to  space group P32l  or  P3t2 l  w i th  un i t  ce l l  parameters  a = b = 103.70 À, . '=
109.84 À with one molecule in the asymmetric unit .  In acldit ion, since MltA shows no
sequence homology with other lyt ic transglycosylases, a selenomethionine substi tuted sMltA
derivative of the enzyme was prepared, puri f ied and crystal l ized to obtain experimental
phases by the mult i-wavelength anomalous dif fract ion (MAD) approach in order to elucidate
the crystal structure.
Chapter 3 gives a detai led descript ion of the 2.0 A resolut ion crystal structure of sMltA
tiorrr E. t t t l i .The structure. obtained using MAD. reveals a novel lyt ic transglycosylase fbld.
sMltA contains two domains, separated by a large groove. Domain A is bui l t  up of two
discorrt inuous amino acid sequence segments (residues 3-104 and 244-331) and consists of an
N-terrninal part (rcsidues 3-90) and a B-barrel core. The N-terminal part contains two
antiparal lel  B-strands (Bl and B2) connected by three hel ices (al-cr3). The B-banel core is the
rni i in Íèature of domain A and consists of a mixed paral lel/antiparal lel  six-stranded closed B-
barre l  made of  B-s t rands B3 and Pl0-814,  wi th  one smal l  c r -he l ix  (u ,9) .  I t  has a  double-ps i  B-
barrel filld toP,
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barrel fbld topology, similar to that of endoglucanase V (EGV) fronl Hunticola insolen.s.
Domain B ( res idues l0-5-243)  is  inser ted between s t rands B3 and Bl0  o f  c lomain A of  sMl tA.
It  also contains a small  mixed paral lel/antiparal lel  six-strurnded B-barrel (9rt-091, and a smit l l
hel ical sub-domain (cr5-cr8). The B-barrel has a dif ferent topolo-ey compared to thc B-bamel
topology of domain A, but is weakly related to the RNA binding domain of r ibosomal
proteins L25 and TL-5.
Comparison of sMltA and the catalyt ic dornain of EGV, combined with rnolecular
modeling studies and site directed mutagenesis experirnents, al lowed us tcl  identi fy structural
regions and important residues involved in substrate binding and catalysis of MltA.
Inrportantly, Asp308. which is in an equivalent posit ion to the catalyt ic acicJ of the H. ir tsoletts
endoglucanase. was assigned as the single : icid/base catalyst in the lyt ic trans-ulycosylase
mechanism. Mr-rtat ion of Asp308 into an alanine residue yielded a completely inactive
enzyme in support of a catalyt ic role of Asp308. At the end of this chapter a general reaction
mechanism is proposed.
To obtain a detai led descript ion of the MltA-peptidoglycan intcractions and the cleavage
mechanism the D308A-sMltA mutant was co-crystal l ized with the substrate analo-gue
chitohexaose. Chapter 4 and chapter 5 deal with the co-crystal l izat ion, the ref ineÍnent
procedure and the structure elucidation of the D308A-sMltA mutant complex.
Because phasing with molecular replacement usins t lre native structLrre fai led, seleniunr-
MAD was used to obtain init ial  phases. However. structure determini i t ion was hanrpered clue
to a rare case of tetartohedral twinning. Therefore, a spccial ref inement protocol was designed
to take tetartohedral twinning into account, which was successfLrl ly appl ied to ref ine the
complex structure. This ref inement protocol is described in chapter 4. The result ing structure
explains the success of usin_q MAD in phasing the data, i is well  as the reasons Ítrr tetartohedral
tw inn ing.
Chapter 5 gives a detai led descript ion of the crystal structure of the D3084-sMltA
mutant in complex with chitohexaose at 2.25 À resolut ion. The chitohexi iose binds to subsites
-4 to  +2 anc l  spans the - l l+ l  c leava-ue s i te .  A l l  s ix  GlcNAc res ic lues have a fu l l  +C;  cha i r
conformation. Interestingly, the complex structure reveals a large conformational change
upon binding the chitohexaose, which results in closure of the active site and t ight interactions
of both domains with the chitohexaose. This confbrmational change is probably necessary Íor




detai led comparison of the MltA cleavage site compared to endoglucanase v. A more detai led
catalyt ic mechanism is proposecl. involving Asp308 as the single catalyt ic acid/base. The
partial negative charge due to the helix dipole moment of cx-helix 5 at the - I a-firce may
stabi l ize the proposed oxo-carbenium ion internrediate. Furthermore. the c-terminus of cr-
hel ix -5 rnay shield the intermediate from the solvent to prevent hydrolysis. No catalyt ic
nucleophile is present. in l ine with other lyt ic transglycosylases rhat have a dif ferent fbld.
Furthernlore. in contrast to other LTs, there is no evidence fbr sMltA that i t  employs substrate
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